RISE: Establishing super-Resolution Imaging in Hull for impactful multimorbidity ReSEarch MRC Equipment bid 2024 - Confocal Imaging ZEISS Elyra 7 with Lattice SIM²

Dr Leonid Nikitenko L.Nikitenko@hull.ac.uk
Lecturer in Biomedical Sciences

Professor John Greenman J.Greenman@hull.ac.uk
Professor of Tumour Immunology

Mr Kevin Oxley

Dr Katie Wraith K.Wraith@hull.ac.uk
Lecturer in Cardiovascular Biology

Dr Andre Voelzmann A.Voelzmann@hull.ac.uk
Lecturer in Cell Biology & Biotechnology

Professor Tim Palmer Tim.Palmer@hull.ac.uk
HYMS Professor of Cardiovascular Biology

Professor Matthew Hardman M.Hardman@hull.ac.uk
Chair in Wound Healing / HYMS Director of Research

Professor Roger Sturmey R.Sturmey@hull.ac.uk
Professor of Reproductive Medicine

Dr Simon Calaminus S.Calaminus@hull.ac.uk
Senior Lecturer

Dr Giordano Pula G.Pula@hull.ac.uk

Dr Holly Wilkinson H.N.Wilkinson@hull.ac.uk
Lecturer in Wound Healing

Dr Amin Ardestani A.Ardestani@hull.ac.uk
Senior Lecturer

Dr Camille Ettelaie C.Ettelaie@hull.ac.uk
Lecturer

Professor Anthony Maraveyas

Dr Paul Hiebert P.Hiebert@hull.ac.uk
Lecturer in Wound Healing

ThrombiGlow: ‘Smart’ Multimodal Platelet Specific ‘Theranostic’ Drug Delivery Imaging Feb 1, 2017 - Jan 31, 2020
Cardiovascular diseases (CVD) including heart attacks and strokes constitute the leading cause of mortality in the UK. The pathology underlying CVD is called atherothrombosis and is a complex, multi-cellular-inflammatory disorder. Central to this is... Read More about ThrombiGlow: ‘Smart’ Multimodal Platelet Specific ‘Theranostic’ Drug Delivery Imaging.

Blood test for clinical therapy guidance of non-small cell lung cancer patients Jan 1, 2017 - Oct 31, 2022
Lung cancer is the most common cancer worldwide. NSCLC alone make up about 75% of all lung cancers and most hospitals currently test all NSCLC patients for EGFR mutations (pharmacogenomics) for treatment decision (personalised medicine) – i.e., patie... Read More about Blood test for clinical therapy guidance of non-small cell lung cancer patients.

TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research Sep 1, 2017 - Dec 31, 2026
The death rate is higher in Yorkshire than the rest of England resulting in about 200 extra deaths each year of which more than half are in Hull. There are other significant cancer outcome inequalities between different groups; for example poorer pe... Read More about TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research.

The role of bacteria in the skin: Cold atmospheric plasma for the treatment of pathological skin healing Apr 1, 2017 - Mar 31, 2020
Chronic wounds remain a major area of unmet clinical need, with infection a principle contributing factor to wound chronicity. This project builds upon strong preliminary data suggesting that healing outcome can be directly linked to both wound micro... Read More about The role of bacteria in the skin: Cold atmospheric plasma for the treatment of pathological skin healing.

MICA: The role of arginase in chronic delayed wound healing Aug 1, 2016 - Oct 17, 2017